Is the use of insulin analogues cost-effective?

被引：0
作者：
Steven Leichter
机构：
[1] Columbus Research Foundation,Center for Diabetes and Metabolism
来源：
Advances in Therapy | 2008年 / 25卷
关键词：
aspart; cost-effectiveness; detemir; glargine; insulin analogues; insulin pens; lispro; pharmacoeconomic models;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many patients with diabetes fail to achieve their glycaemic targets despite clear evidence that glycaemic control can prevent or delay the development of costly complications in diabetes. This article describes how insulin analogues (insulins lispro, aspart, glulisine, glargine and detemir) may have a role to play in overcoming barriers to insulin acceptance and improving adherence with therapy, and examines their cost-effectiveness as determined in published studies.
引用
收藏
页码：285 / 299
页数：14
相关论文
共 177 条
[11]  
Schwartz D.M.(2005)Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes J Manag Care Pharm 11 559-564
[12]  
Shetty S.(2002)Lifetime costs of complications resulting from type 2 diabetes in the US Diabetes Care 25 476-481
[13]  
Secnik K.(2006)Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999–2002: the National Health and Nutrition Examination Survey Diabetes Care 29 531-537
[14]  
Oglesby A.K.(1992)The health belief model and adolescents with insulin-dependent diabetes mellitus Health Psychol 11 190-198
[15]  
Caro J.J.(2004)The relationship of health beliefs and complication prevention behaviors of Chinese individuals with type 2 diabetes mellitus Diabetes Res Clin Pract 66 71-77
[16]  
Ward A.J.(1997)NIDDM patients’ fears and hopes about insulin therapy. The basis of patient reluctance Diabetes Care 20 292-298
[17]  
O’Brien J.A.(2005)The International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: results of the crossnational Diabetes Attitudes, Wishes, and Needs (DAWN) study Diabetes Care 28 2673-2679
[18]  
Resnick H.E.(2002)When oral agents fail: practical barriers to starting insulin Int J Obes Relat Metab Disord 26 S18-S24
[19]  
Foster G.L.(2004)Hypoglycemia as a barrier to glycemic control J Diabetes Complications 18 60-68
[20]  
Bardsley J.(2004)A systematic review of adherence with medications for diabetes Diabetes Care 27 1218-1224
12345678910